REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

S Group Pharma S.R.O. (Slovakia)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Wholesale Trade Agents and Brokers
Secondary Activities: All Other Business Support Services
Full name: S Group Pharma S.R.O. Profile Updated: October 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

S Group Pharma S.R.O. is based in Slovakia, with the head office in Nitrianske Rudno. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. S Group Pharma S.R.O. was incorporated on February 11, 2016. From the latest financial highlights, S Group Pharma S.R.O. reported a net sales revenue increase of 40.27% in 2024. There was a total growth of 12.33% in S Group Pharma S.R.O.’s total assets over the same period. S Group Pharma S.R.O.’s net profit margin increased by 2.32% in 2024.

Headquarters
Hlavna, 545/81
Nitrianske Rudno; Postal Code: 97226

Contact Details: Purchase the S Group Pharma S.R.O. report to view the information.

Basic Information
Registered Capital:
Purchase the S Group Pharma S.R.O. report to view the information.
Financial Auditors:
Purchase the S Group Pharma S.R.O. report to view the information.
Incorporation Date:
February 11, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after S Group Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
40.27%▲
Total operating revenue
39.77%▲
Operating profit (EBIT)
148.36%▲
EBITDA
71.27%▲
Net Profit (Loss) for the Period
280.77%▲
Total Assets
12.33%▲
Total Equity
54.66%▲
Operating Profit Margin (ROS)
2.29%▲
Net Profit Margin
2.32%▲
Return on Equity (ROE)
20.98%▲
Debt/Equity
-59.66%▼
Quick Ratio
-0.45%▼
Cash Ratio
-0.67%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo